首页> 外文期刊>Vaccine >Tularemia vaccine: Safety, reactogenicity, 'Take' skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial
【24h】

Tularemia vaccine: Safety, reactogenicity, 'Take' skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial

机译:Tularemia疫苗:安全性,反应源性,“服用”皮肤反应,并在疫苗接种后用新的繁殖疫苗活疫苗菌株 - A 2阶段随机临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Tularemia is caused by Francisella tularensis, a gram-negative bacterium that has been weaponized as an,aerosol. For protection of personnel conducting biodefense research, the United States Army required clinical evaluation of a new lot of tularemia live vaccine strain manufactured in accordance with Current Good Manufacturing Practices.
机译:背景:Tularemia是由Francisella Tularensis引起的,这是一种被武器化的革兰氏阴性细菌作为气溶胶。 为了保护生物义研究的人员,美国陆军要求根据当前良好的制造实践制造的新型大型术疫苗菌株的临床评价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号